Annual Cash & Cash Equivalents
$269.50M$73.60M+37.57%
Summary
- Current Value
- As of today, SGRY annual cash & cash equivalents is $269.50M, up +37.57% on
- Historical Performance
- SGRY annual cash & cash equivalents is down -30.88% over the past 3 years, and up +190.72% over the past 5 years
- All-Time High Comparison
- SGRY annual cash & cash equivalents is currently -30.88% below its historical high of $389.90M set on
- 3-Year Low Comparison
- SGRY annual cash & cash equivalents is +37.57% above its 3-year low of $195.90M reached on
- Sector Comparison
- SGRY annual cash & cash equivalents is higher than 82.17% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $269.50M | +37.6% | -30.9% | +190.7% | +100.0% | |
| Quarterly Cash & Cash Equivalents | $203.40M | -8.3% | +31.4% | -54.8% | – | |
| Price | $16.12 | -24.1% | -43.6% | -46.8% | – | |
| Annual Current Assets | $1.12B | +25.1% | +18.3% | +113.0% | +100.0% | |
| Annual Total Liabilities | $4.37B | +19.6% | +11.0% | +27.1% | +100.0% | |
| Annual Working Capital | $495.00M | +33.1% | +20.9% | +288.5% | +100.0% | |
| Annual Net Income | $12.50M | -90.8% | -79.3% | -72.3% | -51.7% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $282.90M | N/A | -4.7% |
| 5Y | $389.90M | -30.9% | |
| All | $389.90M | -30.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $195.90M | +37.6% | |
| 5Y | $195.90M | +37.6% | |
| All | $0.00 | N/A |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of SGRY?
As of today, SGRY annual cash & cash equivalents is $269.50M
What is 1-year change in SGRY annual cash & cash equivalents?
SGRY annual cash & cash equivalents is up +37.57% year-over-year
What is 3-year change in SGRY annual cash & cash equivalents?
SGRY annual cash & cash equivalents is down -30.88% over the past 3 years
How far is SGRY annual cash & cash equivalents from its all-time high?
SGRY annual cash & cash equivalents is currently -30.88% below its historical high of $389.90M set on December 31, 2021
How does SGRY annual cash & cash equivalents rank versus sector peers?
SGRY annual cash & cash equivalents is higher than 82.17% of companies in Healthcare sector
When is SGRY next annual earnings release?
The next annual earnings release for SGRY is on
Quarterly Cash & Cash Equivalents
$203.40M$46.70M-18.67%
Summary
- Current Value
- As of today, SGRY quarterly cash & cash equivalents is $203.40M, down -18.67% on
- Historical Performance
- SGRY quarterly cash & cash equivalents is down -8.30% year-over-year, and up +31.40% over the past 3 years
- All-Time High Comparison
- SGRY quarterly cash & cash equivalents is currently -62.47% below its historical high of $541.90M set on
- 3-Year Low Comparison
- SGRY quarterly cash & cash equivalents is +14.66% above its 3-year low of $177.40M reached on
- Sector Comparison
- SGRY quarterly cash & cash equivalents is higher than 69.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $203.40M | -18.7% | -8.3% | +31.4% | -54.8% | |
| Annual Cash & Cash Equivalents | $269.50M | – | +37.6% | -30.9% | +190.7% | |
| Price | $16.12 | -20.7% | -24.1% | -43.6% | -46.8% | |
| Quarterly Current Assets | $1.10B | -0.3% | +6.4% | +49.3% | +23.4% | |
| Quarterly Total Liabilities | $4.39B | +0.4% | +10.2% | +7.4% | +16.1% | |
| Quarterly Working Capital | $516.20M | -3.0% | +12.1% | +352.8% | +70.6% | |
| Quarterly Net Income | $25.30M | -43.6% | +295.3% | +351.8% | +173.8% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $269.50M | N/A | -24.5% |
| 3Y | $282.90M | N/A | -28.1% |
| 5Y | $541.90M | -62.5% | |
| All | $541.90M | -62.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $203.40M | at low | |
| 3Y | $177.40M | +14.7% | |
| 5Y | $154.80M | +31.4% | |
| All | $56.42M | +260.5% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of SGRY?
As of today, SGRY quarterly cash & cash equivalents is $203.40M
What is SGRY quarterly cash & cash equivalents most recent change?
SGRY quarterly cash & cash equivalents was down -18.67% on September 30, 2025
What is 1-year change in SGRY quarterly cash & cash equivalents?
SGRY quarterly cash & cash equivalents is down -8.30% year-over-year
How far is SGRY quarterly cash & cash equivalents from its all-time high?
SGRY quarterly cash & cash equivalents is currently -62.47% below its historical high of $541.90M set on March 31, 2021
How does SGRY quarterly cash & cash equivalents rank versus sector peers?
SGRY quarterly cash & cash equivalents is higher than 69.66% of companies in Healthcare sector
When is SGRY next earnings release?
The next earnings release for SGRY is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- SGRY Official Website www.surgerypartners.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1638833/000163883325000163/0001638833-25-000163-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1638833/000163883325000053/0001638833-25-000053-index.htm
- SGRY Profile on Yahoo Finance finance.yahoo.com/quote/SGRY
- SGRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgry